Medical Care
Global Myasthenia Gravis (MG) Treatment Market Research Report 2025
- Sep 18, 25
- ID: 507029
- Pages: 75
- Figures: 79
- Views: 12
This report aims to provide a comprehensive presentation of the global market for Myasthenia Gravis (MG) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myasthenia Gravis (MG) Treatment.
The Myasthenia Gravis (MG) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myasthenia Gravis (MG) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myasthenia Gravis (MG) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion Pharmaceutical
Grifols
Avadel Pharmaceuticals
Novartis
Pfizer
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Bausch Health Companies
Shire
Segment by Type
Drug Treatment
Rapid Immunotherapies
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis (MG) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Myasthenia Gravis (MG) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Myasthenia Gravis (MG) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Myasthenia Gravis (MG) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion Pharmaceutical
Grifols
Avadel Pharmaceuticals
Novartis
Pfizer
AbbVie
F. Hoffmann-La Roche
GlaxoSmithKline
Bausch Health Companies
Shire
Segment by Type
Drug Treatment
Rapid Immunotherapies
Others
Segment by Application
Hospitals and Clinics
Diagnostic Centers
Academic and Research Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis (MG) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Treatment
1.2.3 Rapid Immunotherapies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis (MG) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis (MG) Treatment Market Perspective (2020-2031)
2.2 Global Myasthenia Gravis (MG) Treatment Growth Trends by Region
2.2.1 Global Myasthenia Gravis (MG) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Myasthenia Gravis (MG) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Myasthenia Gravis (MG) Treatment Market Dynamics
2.3.1 Myasthenia Gravis (MG) Treatment Industry Trends
2.3.2 Myasthenia Gravis (MG) Treatment Market Drivers
2.3.3 Myasthenia Gravis (MG) Treatment Market Challenges
2.3.4 Myasthenia Gravis (MG) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue (2020-2025)
3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Myasthenia Gravis (MG) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Myasthenia Gravis (MG) Treatment Revenue
3.4 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis (MG) Treatment Revenue in 2024
3.5 Global Key Players of Myasthenia Gravis (MG) Treatment Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
3.7 Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis (MG) Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031)
5 Myasthenia Gravis (MG) Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
6.2 North America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
6.4 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
7.2 Europe Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
7.4 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
9.2 Latin America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
9.4 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceutical
11.1.1 Alexion Pharmaceutical Company Details
11.1.2 Alexion Pharmaceutical Business Overview
11.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Introduction
11.1.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.1.5 Alexion Pharmaceutical Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Myasthenia Gravis (MG) Treatment Introduction
11.2.4 Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Avadel Pharmaceuticals
11.3.1 Avadel Pharmaceuticals Company Details
11.3.2 Avadel Pharmaceuticals Business Overview
11.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Introduction
11.3.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.3.5 Avadel Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Myasthenia Gravis (MG) Treatment Introduction
11.4.4 Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Myasthenia Gravis (MG) Treatment Introduction
11.5.4 Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Myasthenia Gravis (MG) Treatment Introduction
11.6.4 AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Details
11.9.2 Bausch Health Companies Business Overview
11.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Introduction
11.9.4 Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.9.5 Bausch Health Companies Recent Development
11.10 Shire
11.10.1 Shire Company Details
11.10.2 Shire Business Overview
11.10.3 Shire Myasthenia Gravis (MG) Treatment Introduction
11.10.4 Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.10.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Treatment
1.2.3 Rapid Immunotherapies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Myasthenia Gravis (MG) Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.3.4 Academic and Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis (MG) Treatment Market Perspective (2020-2031)
2.2 Global Myasthenia Gravis (MG) Treatment Growth Trends by Region
2.2.1 Global Myasthenia Gravis (MG) Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Myasthenia Gravis (MG) Treatment Historic Market Size by Region (2020-2025)
2.2.3 Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031)
2.3 Myasthenia Gravis (MG) Treatment Market Dynamics
2.3.1 Myasthenia Gravis (MG) Treatment Industry Trends
2.3.2 Myasthenia Gravis (MG) Treatment Market Drivers
2.3.3 Myasthenia Gravis (MG) Treatment Market Challenges
2.3.4 Myasthenia Gravis (MG) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue
3.1.1 Global Top Myasthenia Gravis (MG) Treatment Players by Revenue (2020-2025)
3.1.2 Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Myasthenia Gravis (MG) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Myasthenia Gravis (MG) Treatment Revenue
3.4 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio
3.4.1 Global Myasthenia Gravis (MG) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis (MG) Treatment Revenue in 2024
3.5 Global Key Players of Myasthenia Gravis (MG) Treatment Head office and Area Served
3.6 Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
3.7 Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis (MG) Treatment Breakdown Data by Type
4.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Type (2020-2025)
4.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031)
5 Myasthenia Gravis (MG) Treatment Breakdown Data by Application
5.1 Global Myasthenia Gravis (MG) Treatment Historic Market Size by Application (2020-2025)
5.2 Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
6.2 North America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
6.4 North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
7.2 Europe Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
7.4 Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
8.2 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
9.2 Latin America Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
9.4 Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size (2020-2031)
10.2 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion Pharmaceutical
11.1.1 Alexion Pharmaceutical Company Details
11.1.2 Alexion Pharmaceutical Business Overview
11.1.3 Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Introduction
11.1.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.1.5 Alexion Pharmaceutical Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Myasthenia Gravis (MG) Treatment Introduction
11.2.4 Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Avadel Pharmaceuticals
11.3.1 Avadel Pharmaceuticals Company Details
11.3.2 Avadel Pharmaceuticals Business Overview
11.3.3 Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Introduction
11.3.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.3.5 Avadel Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Myasthenia Gravis (MG) Treatment Introduction
11.4.4 Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Myasthenia Gravis (MG) Treatment Introduction
11.5.4 Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Myasthenia Gravis (MG) Treatment Introduction
11.6.4 AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.6.5 AbbVie Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Myasthenia Gravis (MG) Treatment Introduction
11.8.4 GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Details
11.9.2 Bausch Health Companies Business Overview
11.9.3 Bausch Health Companies Myasthenia Gravis (MG) Treatment Introduction
11.9.4 Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.9.5 Bausch Health Companies Recent Development
11.10 Shire
11.10.1 Shire Company Details
11.10.2 Shire Business Overview
11.10.3 Shire Myasthenia Gravis (MG) Treatment Introduction
11.10.4 Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025)
11.10.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Rapid Immunotherapies
Table 4. Key Players of Others
Table 5. Global Myasthenia Gravis (MG) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Myasthenia Gravis (MG) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2025)
Table 9. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2026-2031)
Table 11. Myasthenia Gravis (MG) Treatment Market Trends
Table 12. Myasthenia Gravis (MG) Treatment Market Drivers
Table 13. Myasthenia Gravis (MG) Treatment Market Challenges
Table 14. Myasthenia Gravis (MG) Treatment Market Restraints
Table 15. Global Myasthenia Gravis (MG) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players (2020-2025)
Table 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
Table 18. Ranking of Global Top Myasthenia Gravis (MG) Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis (MG) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Myasthenia Gravis (MG) Treatment, Headquarters and Area Served
Table 21. Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
Table 22. Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Alexion Pharmaceutical Company Details
Table 48. Alexion Pharmaceutical Business Overview
Table 49. Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Product
Table 50. Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 51. Alexion Pharmaceutical Recent Development
Table 52. Grifols Company Details
Table 53. Grifols Business Overview
Table 54. Grifols Myasthenia Gravis (MG) Treatment Product
Table 55. Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Avadel Pharmaceuticals Company Details
Table 58. Avadel Pharmaceuticals Business Overview
Table 59. Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Product
Table 60. Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 61. Avadel Pharmaceuticals Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Myasthenia Gravis (MG) Treatment Product
Table 65. Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Myasthenia Gravis (MG) Treatment Product
Table 70. Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Myasthenia Gravis (MG) Treatment Product
Table 75. AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. F. Hoffmann-La Roche Company Details
Table 78. F. Hoffmann-La Roche Business Overview
Table 79. F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Product
Table 80. F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 81. F. Hoffmann-La Roche Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Myasthenia Gravis (MG) Treatment Product
Table 85. GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bausch Health Companies Company Details
Table 88. Bausch Health Companies Business Overview
Table 89. Bausch Health Companies Myasthenia Gravis (MG) Treatment Product
Table 90. Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 91. Bausch Health Companies Recent Development
Table 92. Shire Company Details
Table 93. Shire Business Overview
Table 94. Shire Myasthenia Gravis (MG) Treatment Product
Table 95. Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 96. Shire Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Myasthenia Gravis (MG) Treatment Picture
Figure 2. Global Myasthenia Gravis (MG) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Myasthenia Gravis (MG) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Treatment Features
Figure 5. Rapid Immunotherapies Features
Figure 6. Others Features
Figure 7. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Academic and Research Organizations Case Studies
Figure 12. Myasthenia Gravis (MG) Treatment Report Years Considered
Figure 13. Global Myasthenia Gravis (MG) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Myasthenia Gravis (MG) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Myasthenia Gravis (MG) Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players in 2024
Figure 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Myasthenia Gravis (MG) Treatment Revenue in 2024
Figure 19. North America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 21. United States Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 25. Germany Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2031)
Figure 33. China Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 49. Grifols Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 50. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 53. AbbVie Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 56. Bausch Health Companies Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 57. Shire Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Rapid Immunotherapies
Table 4. Key Players of Others
Table 5. Global Myasthenia Gravis (MG) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Myasthenia Gravis (MG) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2025)
Table 9. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Myasthenia Gravis (MG) Treatment Market Share by Region (2026-2031)
Table 11. Myasthenia Gravis (MG) Treatment Market Trends
Table 12. Myasthenia Gravis (MG) Treatment Market Drivers
Table 13. Myasthenia Gravis (MG) Treatment Market Challenges
Table 14. Myasthenia Gravis (MG) Treatment Market Restraints
Table 15. Global Myasthenia Gravis (MG) Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players (2020-2025)
Table 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
Table 18. Ranking of Global Top Myasthenia Gravis (MG) Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Myasthenia Gravis (MG) Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Myasthenia Gravis (MG) Treatment, Headquarters and Area Served
Table 21. Global Key Players of Myasthenia Gravis (MG) Treatment, Product and Application
Table 22. Global Key Players of Myasthenia Gravis (MG) Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Myasthenia Gravis (MG) Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Myasthenia Gravis (MG) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Myasthenia Gravis (MG) Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Alexion Pharmaceutical Company Details
Table 48. Alexion Pharmaceutical Business Overview
Table 49. Alexion Pharmaceutical Myasthenia Gravis (MG) Treatment Product
Table 50. Alexion Pharmaceutical Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 51. Alexion Pharmaceutical Recent Development
Table 52. Grifols Company Details
Table 53. Grifols Business Overview
Table 54. Grifols Myasthenia Gravis (MG) Treatment Product
Table 55. Grifols Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Avadel Pharmaceuticals Company Details
Table 58. Avadel Pharmaceuticals Business Overview
Table 59. Avadel Pharmaceuticals Myasthenia Gravis (MG) Treatment Product
Table 60. Avadel Pharmaceuticals Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 61. Avadel Pharmaceuticals Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Myasthenia Gravis (MG) Treatment Product
Table 65. Novartis Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Myasthenia Gravis (MG) Treatment Product
Table 70. Pfizer Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Myasthenia Gravis (MG) Treatment Product
Table 75. AbbVie Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. F. Hoffmann-La Roche Company Details
Table 78. F. Hoffmann-La Roche Business Overview
Table 79. F. Hoffmann-La Roche Myasthenia Gravis (MG) Treatment Product
Table 80. F. Hoffmann-La Roche Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 81. F. Hoffmann-La Roche Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Myasthenia Gravis (MG) Treatment Product
Table 85. GlaxoSmithKline Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Bausch Health Companies Company Details
Table 88. Bausch Health Companies Business Overview
Table 89. Bausch Health Companies Myasthenia Gravis (MG) Treatment Product
Table 90. Bausch Health Companies Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 91. Bausch Health Companies Recent Development
Table 92. Shire Company Details
Table 93. Shire Business Overview
Table 94. Shire Myasthenia Gravis (MG) Treatment Product
Table 95. Shire Revenue in Myasthenia Gravis (MG) Treatment Business (2020-2025) & (US$ Million)
Table 96. Shire Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Myasthenia Gravis (MG) Treatment Picture
Figure 2. Global Myasthenia Gravis (MG) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Myasthenia Gravis (MG) Treatment Market Share by Type: 2024 VS 2031
Figure 4. Drug Treatment Features
Figure 5. Rapid Immunotherapies Features
Figure 6. Others Features
Figure 7. Global Myasthenia Gravis (MG) Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Myasthenia Gravis (MG) Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Diagnostic Centers Case Studies
Figure 11. Academic and Research Organizations Case Studies
Figure 12. Myasthenia Gravis (MG) Treatment Report Years Considered
Figure 13. Global Myasthenia Gravis (MG) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Myasthenia Gravis (MG) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Myasthenia Gravis (MG) Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Myasthenia Gravis (MG) Treatment Market Share by Players in 2024
Figure 17. Global Top Myasthenia Gravis (MG) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis (MG) Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Myasthenia Gravis (MG) Treatment Revenue in 2024
Figure 19. North America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 21. United States Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 25. Germany Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Myasthenia Gravis (MG) Treatment Market Share by Region (2020-2031)
Figure 33. China Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Myasthenia Gravis (MG) Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Myasthenia Gravis (MG) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 49. Grifols Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 50. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 52. Pfizer Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 53. AbbVie Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 54. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 56. Bausch Health Companies Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 57. Shire Revenue Growth Rate in Myasthenia Gravis (MG) Treatment Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232